Skip to main content

Chemotherapy in Advanced Soft Tissue Sarcoma — The EORTC Experience

  • Chapter
Recent Concepts in Sarcoma Treatment

Abstract

The Soft Tissue and Bone Sarcoma Group (STBSG) is one of the 17 clinical cooperative groups of the European Organization for Research and Treatment of Cancer (EORTC). It was constituted in 1975 and increased from nine full members in 1976 to 21 full and 11 probational members from nine European countries by 1987.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. WHO. Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication, Number 48, Geneva, 1979.

    Google Scholar 

  2. Pinedo HM, Bramwell VHC, Mouridsen HT, Somers R, Vendrik CPJ, Santoro A, Buesa J, Wagener Th, van Oosterom AT, van Unnik JAM, Sylvester R, De Pauw M, Thomas D, Bonadonna G: Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer 53:1825–1832, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Gottlieb JA, Baker LH, O’Bryan RM, et al.: Adriamycin (NSC-123127) used alone and in combination for soft tissue and bone sarcomas. Cancer Chemother Rep 6:271–282, 1975.

    Google Scholar 

  4. Yap BS, Baker LH, Sinkovics JG, et al.: Cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64:93–98, 1980.

    PubMed  CAS  Google Scholar 

  5. Bramwell VHC, Pinedo HM: Bone and soft tissue sarcomas. In HM Pinedo, (ed.): Cancer Chemotherapy. The EORTC Cancer Chemotherapy Annual 1. Excerpta Medica 1979:424–450.

    Google Scholar 

  6. Bramwell VHC, Pinedo HM: Bone and soft tissue sarcomas. In HM Pinedo (ed.): Cancer Chemotherapy. The EORTC Cancer Chemotherapy Annual 2. Excerpta Medica 1980:393–414.

    Google Scholar 

  7. Perevudchikova NI, Lichinityer MR, Gorbunova VA: Phase I clinical study of carminomycin: its activity against soft tissue sarcoma. Cancer Treat Rep 61:1705, 1977.

    Google Scholar 

  8. Bramwell VHC, Mouridsen HT, Mulder JH, Somers R, Van Oosterom AT, Santoro A, Thomas D, Sylvester R, Markham D: Carminomycin versus Adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study. Eur J of Cancer and Clin Oncol 19:1097–1104, 1983.

    Article  CAS  Google Scholar 

  9. Mouridsen HT, Somers R, Santoro A, Mulder JH, Bramwell V, Van Oosterom AT, Sylvester R, Thomas D, Pinedo HM: Doxorubicin versus epirubicin in advanced soft tissue sarcomas. An EORTC randomized phase II study. In. Advances in anthracycline chemotherapy: epirubicin. G. Bonadonna (Ed.), pp. 95–103, 1984. ISBN 88.214.1715.8.

    Google Scholar 

  10. Stuart-Harris RC, Harper PG, Parsons CA et al.: High dose alkylation therapy using Ifosfamide infusion with Mesna in the treatment of adult advanced soft tissue sarcoma. Cancer Chemother Pharm 11:69–72, 1983.

    Article  CAS  Google Scholar 

  11. Bramwell VHC, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, Van Oosterom AT (for the European Organization for Research and Treatment of Cancer, Soft Tissue and Bone Sarcoma Group: Cyclophosphamide versus Ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer and Clin Oncol 23:311–323, 1987.

    Article  CAS  Google Scholar 

  12. Schütte J, Dombernowsky P, Santoro A, Stewart W, Mouridsen HT, Somers R, Van Oosterom AT, Blackledge G, Thomas D, Sylvester R (1986): Adriamycin (A) and ifosfamide (I), a new effective combination in advanced soft tissue sarcoma. Preliminary report of a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Proc Eur Conf Clin Oncol, 4:232, 1987.

    Google Scholar 

  13. Santoro A: Personal communication, 1987.

    Google Scholar 

  14. Bramwell VHC, Brugarolas A, Mouridsen HT, Cheix F, de Jager R, Van Oosterom AT, Vendrik CPJ, Pinedo HM, Sylvester R, De Pauw M: EORTC phase II study of Cisplatin in CyVADIC resistant soft tissue sarcomas. Eur J Cancer 15:1511–1513, 1979.

    Article  PubMed  CAS  Google Scholar 

  15. Mouridsen HT, Bramwell VHC, Lacave J, Metz R, Vendrik CPJ, Hild J, Mc Creanney J, Sylvester R: Treatment of advanced soft tissue sarcomas with chlorozotocin. a phase II trial of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer Treat Rep 65:509–511, 1981.

    PubMed  CAS  Google Scholar 

  16. Buesa JM, Mouridsen HT, Santoro A, Somers R, Bramwell V, Van Oosterom AT, Wagener Th, Vendrik C, Thomas D: Treatment of advanced soft tissue sarcomas with low-dose Methotrexate: a phase II trial by the European Organization for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group, Cancer Treat Rep, 68:683, 1984.

    PubMed  CAS  Google Scholar 

  17. Bramwell V, Van Oosterom AT, Mouridsen HT, Cheix F, Somers R, Thomas D, Rozencweig MN: -(Phosphonacetyl)-L-Aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer and Clin Oncol 18:81–84, 1982.

    Article  CAS  Google Scholar 

  18. Somers R, Rouessé J, Van Oosterom AT, Thomas D: Phase II study of elliptinium in metastatic soft tissue sarcoma. Eur J Cancer Clin Oncol 21:591–593, 1985.

    Article  PubMed  CAS  Google Scholar 

  19. Van Oosterom AT, Santoro A, Bramwell V, Davy M, Mouridsen HT, Thomas D, Sylvester R: Mitomycin C (MMc) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol 21:459–461, 1985.

    Article  PubMed  Google Scholar 

  20. Dombernowsky P, Buesa J, Pinedo HM, Santoro A, Mouridsen H, Somers R, Bramwell V, Onsrud M, Rouessé J, Thomas D, Sylvester R: VP 16 (Etoposide) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol 23:579, 1987.

    Article  PubMed  CAS  Google Scholar 

  21. Blackledge G, Van Oosterom AT, Mouridsen HT, et al.: Treatment of advanced soft tissue sarcomas with adriamycin in second line. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Submitted for publication.

    Google Scholar 

  22. Buesa JM, Mouridsen H, Van Oosterom AT, Steward WT, Verwey J, Thomas D: High-dose DTIC in advanced soft-tissue sarcomas (STS) of the adult. A phase II study of the EORTC Soft-Tissue and Bone Sarcoma Group. Program and Abstracts, fifth NCI EORTC Symposium on new drugs in cancer therapy. Amsterdam nr. 2.20, 1986.

    Google Scholar 

  23. Rouessé J, Van Oosterom AT, Kerbrat P, Cappelaere P, Pinedo H, Thomas D, Benshahar D: Phase II study of 1,2,4 triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of EORTC’s Soft Tissue and Bone Sarcoma Cooperative Group. Eur J Cancer Clin Oncol 21:1413–1414, 1987.

    Article  Google Scholar 

  24. Steward WP, Somers R, Kerbrat P, Verwey J, Buesa J, et al: Phase II study of Methyleen dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adults. (in preparation).

    Google Scholar 

  25. Somers R: Personal communication.

    Google Scholar 

  26. Van Oosterom AT, Bramwell VHC, Mouridsen HT, Somers R, Santoro A, Buesa J, Vendrik CP, Rouessé J, Dombernowsky P, Pinedo HM, Thomas D, Sylvester R: Review of the EORTC Soft Tissue and Bone Sarcoma Group’s Phase II studies in advanced soft tissue sarcomas. In Management of Soft Tissue and Bone Sarcomas. Van Oosterom AT, van Unnik JAM (eds.), EORTC monograph, vol. 16, Raven Press, New York, pp. 161–167, 1986.

    Google Scholar 

  27. Verwey J: Personal communication.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers

About this chapter

Cite this chapter

Van Oosterom, A.T. et al. (1988). Chemotherapy in Advanced Soft Tissue Sarcoma — The EORTC Experience. In: Ryan, J.R., Baker, L.O. (eds) Recent Concepts in Sarcoma Treatment. Developments in Oncology, vol 55. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2691-2_28

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2691-2_28

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7714-9

  • Online ISBN: 978-94-009-2691-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics